title: Hemodialysis patients with hepatitis C infection are not receiving the new antiviral medications.
authors.affiliation: Arbor Research Collaborative for Health, Ann Arbor, Mich., USA.
authors.forename: David A
authors.initials: DA
authors.lastname: Goodkin
authors.forename: Brian
authors.initials: B
authors.lastname: Bieber
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D009842:Oligopeptides / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D006435:Renal Dialysis; D000069616:Simeprevir / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; C486464:telaprevir; D000069616:Simeprevir